European Society for Medical Oncology (ESMO)

ESMO Sarcoma and Rare Cancers 2024: Robin L. Jones on why you should attend the Congress

ASCO 2023 Highlights on adjuvant osimertinib in resected EGFR mutated NSCLC: The ADAURA trial

Why young oncologists should attend ESMO Asia 2024 - Prof. Lim

ESMO Immuno-Oncology 2024 Congress Experts in the field invite you to share your research.

Claudia Cardone & Andreas Koulouris on how the ESMO Academy helps prepare for the ESMO Examination

Why you should submit your abstract for MAP 2024

#ESMOGynae24

ESMO Immuno-Oncology 2024: Congress Experts in the field invite you to share your research.

MAP 2024: shaping the future of precision oncology

ESMO Immuno-Oncology 2024: Experts in different tumour types explain the importance of this congress

ESMO Asia Congress 2024: multidisciplinary oncology in the Asian region

ESMO/ASCO Global Curriculum in Medical Oncology: Insights on the 2023 Edition

ESMO Immuno-Oncology 2024 Congress M. Maio, A. Marabelle and I. Svane invite you to attend

Why you should attend ESMO Asia 2024 - Prof. Cervantes

ESMO Breast Cancer 2025: Invitation from Scientific Committee Co-Chairs

ESMO Virtual Mentorship Programme

World renowned experts on why you should attend MAP 2024

Recommendations for the use of NGS in patients with metastatic cancer

ESMO Recommendations on clinical reporting of genomics test results for solid cancers

ESMO Women for Oncology Forum 2023: 10 years of ESMO W4O advocating for gender equity

MAP 2024: why you should attend this global congress in precision oncology

ESMO 2024: Join your international community in Barcelona, or Online

Precision Medicine in Prostate Cancer

#ESMO23

ESMO Sarcoma and Rare Cancers 2024: Robin L. Jones on why you should attend the Congress

Highlights on amivantamab after progression on osimertinib in EGFR-mutated NSCLC: MARIPOSA-2

ESMO 2020 Expert Video Report on precision medicine in prostate cancer

How to manage chemotherapy induced nausea and vomiting

Mechanisms of TKI resistance

Interview with Andrés Cervantes, elected ESMO President for 2022-2023

How To treat rectal cancer patients with adjuvant systemic therapy?

#ESMO21

ESMO Targeted Anticancer Therapies Congress 2024: Global Experts On Why You Should Secure Your Seat

How to manage toxicities from Immune Checkpoint Inhibitors?

ESMO 2020 Highlights on 1st line lorlatinib for ALK+ NSCLC: The CROWN Study

Health economics in cancer

ESMO 2020 Expert Video Report on CDK4 6i in the adjuvant treatment of breast cancer

Discrepancies in Cancer Pain Treatment Across the Globe

ESMO Sarcoma and Rare Cancers 2024: The Scientific Committee on why you should attend

Adjuvant treatment for colon cancer: How to treat a stage III colon cancer?

How to protect yourself from coronavirus? The pivotal role of cancer nurses

ESMO Summit Latin America 2024: Invitation from the ESMO President

#ESMO24

Patient-derived xenograft models

Genitourinary Tract Tumours: Essentials for Clinicians

#ESMO21

ESMO Expert Report on combination therapy in advanced prostate cancer @ ASCO GU 2022

ESMO 2018 Congress: Highlights in metastatic triple negative breast cancer LBA1 PR

ASCO 2023 Highlights on the MIRASOL trial in PT-resistant adv. high-grade epithelial Ovarian Cancer

ESMO Sarcoma and Rare Cancers 2024: What you can expect by attending

Unlock your future: Why Young Oncologists should attend MAP 2024